Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Alberta
Study ID
NCT02670408
Status
Recruiting
Apply to this trial

Conditions

  • Cardiac Transplant Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Endomyocardial biopsy — PROCEDURE
    One of several endomyocardial biopsy bites taken as the standard of care. We are asking now for two endomyocardial biopsy bites, to determine tissue sampling variability.

Study Details

Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.

Key Dates

Start date
Jan 31, 2016
Status verified
Jun 2026
Primary completion
Dec 31, 2027
Completion
Jul 31, 2028

Study Design

Enrollment
900 participants (estimated)

Primary Outcome Measure

Assign molecular scores (probability) of T cell mediated rejection, antibody mediated rejection in heart transplant biopsies, in a reference set of 200 biopsies [ Time Frame: 2 years ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Heart InstituteLos AngelesCalifornia90048-
UCLA Medical CentreLos AngelesCalifornia90024-
Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research InstituteDallasTexas75246-
Cardiovascular Medicine, University of Utah HealthSalt Lake CityUtah84132-
Virginia Commonwealth University, Division of CardiologyRichmondVirginia23298-

Find similar trials in Los Angeles, CA

By research site
Cedars-Sinai Heart Institute· Los Angeles, CAUCLA Medical Centre· Los Angeles, CAAnnette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute· Dallas, TXCardiovascular Medicine, University of Utah Health· Salt Lake City, UTVirginia Commonwealth University, Division of Cardiology· Richmond, VA